RTW Biotech Opportunities Ltd USD (RTW.L) LSE

1.63

-0.0011(-0.07%)

Updated at October 21 12:28PM

Currency In USD

Valuation

Market Cap455.64M
Enterprise Value545.44M
P/E Ratio-5.84
PEG Ratio0.02
Price/Sales Ratio15.28
Price/Book Ratio0.96
Enterprise/Revenue18.81
Enterprise/EBITDA-13.64

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-2.63
Operating Margin0.62

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.16

Income Statement

Revenue43.5M
Revenue/Share0.11
Gross Profit38.73M
EBITDA38.89M
Net Income34.18M
Diluted EPS0.1

Balance Sheet

Total Cash2.66M
Total Cash/Share0.01
Total Debt126.3M
Total Debt/Equity0.23
Current Ratio1.26
Book Value Per Share1.77

Price History

52-Week Change4.81
52-Week High1.64
52-Week Low1.08
Moving Average 50 Days1.49
Moving Average 200 Days1.31

Statistics

Average Volume882,991
Shares Outstanding328.17M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A